{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:57:57Z","timestamp":1778633877260,"version":"3.51.4"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"22","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,30]]},"abstract":"<jats:p>Diffuse large B cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma. It is a heterogeneous group of diseases that may need very aggressive treatment in some cases. Prognostic evaluation is very important in determining the best treatment. However, in some clinics, access to genetically based and expensive diagnostic methods is limited. In this study, we analyzed the prognostic value of Hemoglobin, Albumin, Lymphocyte and Platelet (HALP) Score and Geriatric Nutritional Risk Index (GNRI) in DLBCL patients. 201 Patients with newly diagnosed DLBLC between 2005 and 2022 were retrospectively evaluated. Optimal cutoff points for the HALP score and the GNRI were calculated with the receiver operating characteristic curve analysis. Kaplan\u2013Meier method was used to compare survival and disease-free survival times between HALP score groups. In the receiver operating characteristic curve analysis, the cutoff points were found 26.17 for HALP, and 99.17 for GNRI. Groups with lower HALP scores and lower GNRIs had significantly shorter overall survival and disease-free survival. Univariate analyses showed that lower HALP score, lower GNRI and higher lactic dehydrogenase, Ann-Arbor stage, International Prognostic Index (IPI), National Comprehensive Cancer Network-IPI and Revised-IPI scores were associated with worse survival rates (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). According to the results of the multivariate Cox regression model, patients with HALP score\u2005\u2264\u200526.17 (OR: 2.32; 95%CI: 1.31\u20134.11 <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.004) increased the risk of death (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.001, \u22122 loglikelihood\u2005=\u2005506.15). Similarly, a GNRI score\u2005\u2264\u200599.17 was significantly correlated with worse survival outcomes (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001). HALP score and GNRI score are reliable, simple and easily accessible indices that can be used to predict the prognosis of DLBLC patients. DLBLC patients with low HALP score and low GNRI level may be associated with short survival and early nutritional support should be considered.<\/jats:p>","DOI":"10.1097\/md.0000000000042165","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T20:01:24Z","timestamp":1749758484000},"page":"e42165","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["HALP score and GNRI: Simple and powerful prognostic markers in diffuse large B-cell lymphoma"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5398-235X","authenticated-orcid":false,"given":"Tugba","family":"Cetintepe","sequence":"first","affiliation":[{"name":"Department of Hematology, Izmir Katip Celebi University, Ataturk Training and Research Hospital, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1122-6094","authenticated-orcid":false,"given":"Lutfi","family":"Cetintepe","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Izmir Katip Celebi University, Ataturk Training and Research Hospital, Izmir, Turkey."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2448-7346","authenticated-orcid":false,"given":"Demet Kiper","family":"Unal","sequence":"additional","affiliation":[{"name":"Department of Hematology, Izmir Katip Celebi University, Ataturk Training and Research Hospital, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6033-5150","authenticated-orcid":false,"given":"Kemal","family":"Aygun","sequence":"additional","affiliation":[{"name":"Department of Hematology, Izmir Katip Celebi University, Ataturk Training and Research Hospital, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7180-3423","authenticated-orcid":false,"given":"Serife","family":"Solmaz","sequence":"additional","affiliation":[{"name":"Department of Hematology, Izmir Katip Celebi University, Ataturk Training and Research Hospital, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250612","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/annonc\/8.suppl_2.S49","article-title":"Changing trends in the incidence of nonHodgkin\u2019s lymphoma in Europe. Biomed Study Group.","volume":"8","author":"Morgan","year":"1997","journal-title":"Ann Oncol"},{"key":"R2-20250612","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms.","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"R3-20250612","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/j.seminhematol.2023.11.006","article-title":"Biological heterogeneity in diffuse large B-cell lymphoma.","volume":"60","author":"Hilton","year":"2023","journal-title":"Semin Hematol"},{"key":"R4-20250612","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/cancers17010018","article-title":"Improving cure rates for patients with newly diagnosed large B-Cell lymphomas: targeted therapies for high-risk pathologic subgroups as defined by clinical laboratory testing.","volume":"17","author":"Landsburg","year":"2024","journal-title":"Cancers (Basel)"},{"key":"R5-20250612","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and nonHodgkin lymphoma: the Lugano classification.","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"R6-20250612","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199402243300815","article-title":"A predictive model for non-Hodgkin\u2019s lymphoma.","volume":"330","author":"Atkins","year":"1994","journal-title":"N Engl J Med"},{"key":"R7-20250612","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood-2013-09-524108","article-title":"An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era.","volume":"123","author":"Zhou","year":"2014","journal-title":"Blood"},{"key":"R8-20250612","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3109\/10428194.2015.1079319","article-title":"Comparison of International Prognostic Index and NCCN-IPI in 324 patients with de novo diffuse large B-cell lymphoma: a multi-center retrospective analysis.","volume":"57","author":"\u00d6zturk","year":"2016","journal-title":"Leukemia Lymphoma"},{"key":"R9-20250612","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.2019002729","article-title":"International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI.","volume":"135","author":"Ruppert","year":"2020","journal-title":"Blood"},{"key":"R10-20250612","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41392-023-01358-y","article-title":"Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.","volume":"8","author":"Shen","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"R11-20250612","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/ajcn\/82.4.777","article-title":"Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients.","volume":"82","author":"Bouillanne","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"R12-20250612","doi-asserted-by":"crossref","first-page":"41370","DOI":"10.18632\/oncotarget.5629","article-title":"Prognostic significance of the combination of preoperative hemoglobin, albumin, lymphocyte and platelet in patients with gastric carcinoma: a retrospective cohort study.","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"R13-20250612","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3322\/caac.21142","article-title":"Nutrition and physical activity guidelines for cancer survivors.","volume":"62","author":"Rock","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"R14-20250612","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.4103\/0973-1482.137953","article-title":"Changes of serum albumin level and systemic inflammatory response in inoperable non-small cell lung cancer patients after chemotherapy.","volume":"10","author":"Wang","year":"2014","journal-title":"J Cancer Res Ther"},{"key":"R15-20250612","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.clnu.2021.02.005","article-title":"ESPEN practical guideline: clinical nutrition in cancer.","volume":"40","author":"Muscaritoli","year":"2021","journal-title":"Clin Nutr"},{"key":"R16-20250612","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/hon.2233","article-title":"Serum albumin level at diagnosis of diffuse large B-cell lymphoma: an important simple prognostic factor.","volume":"34","author":"Bairey","year":"2016","journal-title":"Hematol Oncol"},{"key":"R17-20250612","doi-asserted-by":"crossref","first-page":"2293514","DOI":"10.1080\/16078454.2023.2293514","article-title":"Prognostic value of lactate dehydrogenase, serum albumin and the lactate dehydrogenase\/albumin ratio in patients with diffuse large B-cell lymphoma.","volume":"29","author":"Wu","year":"2024","journal-title":"Hematology"},{"key":"R18-20250612","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1080\/10428194.2019.1617861","article-title":"Peripheral blood lymphocyte subsets of newly diagnosed DLBCL patients and their dynamic changes with rituximab based immunochemotherapy.","volume":"60","author":"Yang","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"R19-20250612","first-page":"e35654","article-title":"Potential prognostic and predictive role of monocyte and lymphocyte counts on presentation in patients diagnosed with diffuse large B-Cell Lymphoma.","volume":"15","author":"Kharroubi","year":"2023","journal-title":"Cureus"},{"key":"R20-20250612","first-page":"181","article-title":"Anemia associated with worse outcome in diffuse large B-cell lymphoma patients: a single-center retrospective study.","volume":"35","author":"Matsumoto","year":"2018","journal-title":"Turk J Haematol"},{"key":"R21-20250612","first-page":"123","article-title":"A multicenter investigation and analysis on anemia in lymphoma patients in Shanghai.","volume":"41","author":"Shen","year":"2020","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"R22-20250612","first-page":"773","article-title":"The preoperative hemoglobin, albumin, lymphocyte and platelet (HALP) score is a useful predictor in patients with resectable esophageal squamous cell carcinoma.","volume":"21","author":"Feng","year":"2021","journal-title":"Bosn J Basic Med Sci"},{"key":"R23-20250612","doi-asserted-by":"crossref","first-page":"313","DOI":"10.29271\/jcpsp.2022.03.313","article-title":"HALP score as a new prognostic index in metastatic renal cell cancer.","volume":"32","author":"Ekinci","year":"2022","journal-title":"J Coll Physicians Surg Pak"},{"key":"R24-20250612","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7150\/jca.27210","article-title":"The Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score is a novel significant prognostic factor for patients with metastatic prostate cancer undergoing cytoreductive radical prostatectomy.","volume":"10","author":"Guo","year":"2019","journal-title":"J Cancer"},{"key":"R25-20250612","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/s41598-018-19146-y","article-title":"Prognostic significance of HALP (hemoglobin, albumin, lymphocyte and platelet) in patients with bladder cancer after radical cystectomy.","volume":"8","author":"Peng","year":"2018","journal-title":"Sci Rep"},{"key":"R26-20250612","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.12659\/MSM.917968","article-title":"The Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) score in patients with small cell lung cancer before first-line treatment with etoposide and progression-free survival.","volume":"25","author":"Shen","year":"2019","journal-title":"Med Sci Monit"},{"key":"R27-20250612","doi-asserted-by":"crossref","first-page":"976","DOI":"10.21037\/atm-21-2120","article-title":"Predictive value of the hemoglobin, albumin, lymphocyte, and platelet (HALP) score and lymphocyte-to-monocyte ratio (LMR) in patients with non-small cell lung cancer after radical lung cancer surgery.","volume":"9","author":"Zhai","year":"2021","journal-title":"Ann Transl Med"},{"key":"R28-20250612","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/01635581.2022.2142248","article-title":"The prognostic impact of pretreatment geriatric nutritional risk index in patients with diffuse large B-cell lymphoma.","volume":"75","author":"Atas","year":"2023","journal-title":"Nutr Cancer"},{"key":"R29-20250612","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.3390\/cancers15061854","article-title":"Systemic inflammation and lung cancer: is it a real paradigm? Prognostic value of inflammatory indexes in patients with resected non-small-cell lung cancer.","volume":"15","author":"Mazzella","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R30-20250612","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.3390\/cancers15225333","article-title":"The geriatric nutritional risk index predicts prognosis in japanese patients with LATITUDE high-risk metastatic hormone-sensitive prostate cancer: a multi-center study.","volume":"15","author":"Naiki","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R31-20250612","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.3390\/cancers13225852","article-title":"The clinical utility of the geriatric nutritional risk index in predicting postoperative complications and long-term survival in elderly patients with colorectal cancer after curative surgery.","volume":"13","author":"Liao","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R32-20250612","doi-asserted-by":"crossref","first-page":"905292","DOI":"10.3389\/fnut.2022.905292","article-title":"HALP score and GNRI: simple and easily accessible indexes for predicting prognosis in advanced stage NSCLC patients. The \u0130zmir oncology group (IZOG) study.","volume":"9","author":"G\u00fc\u00e7","year":"2022","journal-title":"Front Nutr"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042165","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T20:01:28Z","timestamp":1749758488000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":32,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042165","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]}}}